Exploració per tema "Càncer -- Teràpia"
Ara es mostren els items 1-1 de 1
-
Pharmacophoric modifications lead to superpotent avß3 integrin ligands with suppressed a5ß1 activity
(2014-04-24)
Article
Accés restringit per política de l'editorial
Realitzat a/amb: Technische Universität MünchenThe selective targeting of the avß3 integrin subtype without affecting the structurally closely related receptor a5ß1 is crucial for understanding the details of their biological and pathological functions and thus of great ...